172 related articles for article (PubMed ID: 10170462)
21. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.
Stamm WE; Hicks CB; Martin DH; Leone P; Hook EW; Cooper RH; Cohen MS; Batteiger BE; Workowski K; McCormack WM
JAMA; 1995 Aug; 274(7):545-9. PubMed ID: 7629982
[TBL] [Abstract][Full Text] [Related]
22. Issues in the management of sexually transmitted diseases in Papua New Guinea.
Passey M
P N G Med J; 1996 Sep; 39(3):252-60. PubMed ID: 9795576
[TBL] [Abstract][Full Text] [Related]
23. Pharyngeal gonorrhoea - is dual therapy the way forward?
Sathia L; Ellis B; Phillip S; Winston A; Smith A
Int J STD AIDS; 2007 Sep; 18(9):647-8. PubMed ID: 17785013
[No Abstract] [Full Text] [Related]
24. The efficacy of azithromycin and doxycycline treatment for rectal chlamydial infection: a retrospective cohort study in South Australia.
Li B; Hocking JS; Bi P; Bell C; Fairley CK
Intern Med J; 2018 Mar; 48(3):259-264. PubMed ID: 28967178
[TBL] [Abstract][Full Text] [Related]
25. Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women.
Waugh MA
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():193-8. PubMed ID: 8396093
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of syndromic patient management algorithm for urethral discharge.
Djajakusumah T; Sudigdoadi S; Keersmaekers K; Meheus A
Sex Transm Infect; 1998 Jun; 74 Suppl 1():S29-33. PubMed ID: 10023350
[TBL] [Abstract][Full Text] [Related]
27. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract.
Craig AP; Kong FY; Yeruva L; Hocking JS; Rank RG; Wilson DP; Donovan B
BMC Infect Dis; 2015 Apr; 15():200. PubMed ID: 25925662
[TBL] [Abstract][Full Text] [Related]
28. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.
St Cyr S; Barbee L; Workowski KA; Bachmann LH; Pham C; Schlanger K; Torrone E; Weinstock H; Kersh EN; Thorpe P
MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1911-1916. PubMed ID: 33332296
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial.
Geisler WM; Koltun WD; Abdelsayed N; Burigo J; Mena L; Taylor SN; Batteiger BE; Thurman AR; Hook EW; Vaughn TA; Annett MP; Muenzen RA; Caminis J
Clin Infect Dis; 2012 Jul; 55(1):82-8. PubMed ID: 22431798
[TBL] [Abstract][Full Text] [Related]
30. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings.
Hillis SD; Coles FB; Litchfield B; Black CM; Mojica B; Schmitt K; St Louis ME
Sex Transm Dis; 1998 Jan; 25(1):5-11. PubMed ID: 9437777
[TBL] [Abstract][Full Text] [Related]
31. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
[TBL] [Abstract][Full Text] [Related]
32. Gonorrhoea treatment position statement.
Fifer H; Hughes G; Radcliffe K
Sex Transm Infect; 2015 Aug; 91(5):307. PubMed ID: 26195472
[No Abstract] [Full Text] [Related]
33. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin in gonorrhoea.
Waugh MA
Int J STD AIDS; 1996; 7 Suppl 1():2-4. PubMed ID: 8652723
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis.
Richmond SJ; Bhattacharyya MN; Maiti H; Chowdhury FH; Stirland RM; Tooth JA
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():149-53. PubMed ID: 3182458
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
37. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection.
Horner P
Sex Transm Infect; 2006 Aug; 82(4):340-3. PubMed ID: 16877590
[TBL] [Abstract][Full Text] [Related]
38. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
[TBL] [Abstract][Full Text] [Related]
39. Azithromycin in the management of Chlamydia trachomatis infections.
Ridgway GL
Int J STD AIDS; 1996; 7 Suppl 1():5-8. PubMed ID: 8652727
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
Wendel GD; Cox SM; Bawdon RE; Theriot SK; Heard MC; Nobles BJ
Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1390-6. PubMed ID: 2031520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
